Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 94 (1-2), 123-135
- https://doi.org/10.1016/s0163-7258(02)00176-6
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Differential Regulation of Myocardial NF κ B Following Acute or Chronic TNF- α ExposureJournal of Molecular and Cellular Cardiology, 2001
- Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipientsHuman Immunology, 2001
- Accumulation of LDL in Rat Arteries Is Associated With Activation of Tumor Necrosis Factor-α ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- The involvement of cytokines in the second window of ischaemic preconditioningBritish Journal of Pharmacology, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathyThe Lancet, 1998
- Gene knockout mice as investigative tools in pathophysiologyInternational Journal of Experimental Pathology, 1996
- TNFα receptor expression in rat cardiac myocytes: TNFα inhibition of L‐type Ca2+ current and Ca2+ transientsFEBS Letters, 1995
- Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injuryBiochemical and Biophysical Research Communications, 1992
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990